Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Octagam Market Growth Potential: How Will Market Size Shift Through 2030?
Historically, the growth can be linked to the broadened infrastructure for plasma collection, a rise in the diagnosis of primary immunodeficiencies, the wider clinical adoption of IVIG therapies, an increase in hospital-based infusion treatments, and advancements in plasma fractionation techniques.
The market’s anticipated growth is driven by the increasing occurrence of autoimmune and neurological conditions, its expanding application in managing transplant-related complications, the proliferation of home infusion services, advancements in plasma processing technology, and rising investments in immunotherapy research.
Key trends for the period encompass the escalating application of IVIG in autoimmune disorders, a growing demand for plasma-derived therapies, the broadening scope of immunodeficiency treatment applications, improved safety protocols through pathogen reduction, and an increasing emphasis on standardized immunoglobulin products.
Get A Free Sample Report With In-Depth Market Insights:
Octagam Market Growth Backed By Core Demand Fundamentals
The growing incidence of immunodeficiency disorders is anticipated to drive the expansion of the octagam market moving forward. These disorders are states where the immune system cannot adequately respond to external pathogens or the body’s own cells, leading to autoimmune conditions or a weakened ability to combat infections. The increase in immunodeficiency disorders is linked to elements like environmental toxins, evolving lifestyles, and genetic predispositions, which modify immune system reactions. Octagam supports patient health by providing immunoglobulin therapy to individuals with primary immunodeficiency diseases, thereby helping to avert infections and manage immune system dysfunctions. For instance, in December 2024, data from the U.S. Department of Health & Human Services, a US-based government agency, indicated that in 2023, an estimated 39.9 million people globally were afflicted with HIV, including 38.6 million adults aged 15 and older and 1.4 million children under 15, with approximately 53% being women and girls. Thus, the escalating presence of immunodeficiency disorders is propelling the growth of the octagam market.
Octagam Market Segmentation: How Does The Market Break Down By Category?
The octagam market covered in this report is segmented –
1) By Indication: Primary Humoral Immunodeficiency, Chronic Immune Thrombocytopenic Purpura, Dermatomyositis, Bone Marrow Transplantation, AIDS
2) By Formulation: 5% Liquid Preparation, 10% Liquid Preparation
3) By Distribution Channel: Pharmacies, Online Pharmacies
Octagam Market Growth Trends Reshaping The Competitive Landscape
Key companies active in the Octagam market are concentrating on strengthening supply resilience, employing methods like a high-concentration intravenous immunoglobulin product profile synopsis to improve clinical understanding and regulatory compliance. A high-concentration intravenous immunoglobulin product profile synopsis is defined as a structured technical overview that details the essential attributes, clinical specifications, and safety-related information of a concentrated intravenous immunoglobulin formulation. For example, in March 2025, Octapharma, a Switzerland-based plasma products firm, released Gamten 10% IVIg, a 10% human normal immunoglobulin solution produced from UK-sourced plasma, which boosts self-sufficiency, preserves the identical formulation and clinical profile as Octagam 10%, and delivers high purity with = 95% IgG and an IgA content of = 0.4 mg/ml.
Octagam Market Competitive Overview And Top Companies
Major companies operating in the octagam market are Octapharma AG
View The Full Octagam Market Report:
Octagam Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the octagam market in 2025. The regions covered in the octagam market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model